Novo Nordisk And 2 Other Top Dividend Stocks

With a senior Federal Reserve official warning that the fight against inflation may be painful and involve higher interest rates, dependable cash payouts suddenly look far more attractive. Regular dividend income can help smooth out returns when borrowing costs stay elevated and market swings feel harsher. This article looks at three high-yield stocks that currently offer more than a 3% dividend, supported by coverage metrics that appear strong and payouts that have shown stability and growth.

The three stocks covered below are only a small sample of the idea, and the full screen surfaced another 2,258 listed businesses with dividend yields above 3% that meet the same coverage and stability filters but are not discussed here.

If you want to go straight to the source and identify candidates that match your own risk, income and quality thresholds, head into the Dividend Powerhouses (3%+ Yield) screener to filter, analyze, and focus on the highest conviction dividend payers.

Novo Nordisk (CPSE:NOVO B)

Overview: Novo Nordisk is a global pharmaceutical group focused on diabetes and obesity treatments that generate recurring cash flows supporting its dividend.

Operations: Novo Nordisk earns about DKK 309b from Diabetes and Obesity Care and DKK 20b from Rare Disease therapies, anchored in GLP-1 treatments.

Market Cap: DKK 1,150b

Novo Nordisk matters in a dividend-focused screen because its Diabetes and Obesity Care franchise generates substantial recurring cash that supports shareholder payouts, while investors evaluate how durable that income stream is.

"The surge in demand from GLP-1-based drugs semaglutide (Ozempic and Wegovy) has brought tens of billions of dollars in revenue and transformed Novo Nordisk into Europe’s most valuable publicly traded company. Its future risk is potential increased regulatory scrutiny or competition from biosimilars."

Investors may also consider what could happen to Novo Nordisk’s premium income stream if a single key pressure on future pricing power does not resolve in its favor.

If that pricing pressure is exactly what you are weighing, read the full narrative for Novo Nordisk to see how Novo Nordisk’s dividend story could continue through shifting risks.

Kaspi.kz (KSPI)

Overview: Kaspi.kz runs a super-app across Kazakhstan and nearby markets that combines payments, shopping, and consumer finance into one platform.

Operations: Kaspi.kz generates about KZT 2.15t from Marketplace, KZT 1.71t from Fintech, and KZT 677b from Payments, with most revenue from Kazakhstan and other markets rather than Turkey.

Market Cap: US$18.53b

Kaspi.kz matters for a dividend-focused screen because its Payments segment provides steady, fee-based cash flow that can help support regular distributions, while the broader platform focuses on scaling marketplace and lending.

"Continued expansion and high engagement in payments, marketplace, and fintech super-app ecosystem are fueling cross-selling and deeper user integration, supporting higher long-term take rates and sustained revenue expansion."

The strength of that dividend profile will depend on how one pressure on profitability develops relative to the cash generation in Payments.

That profitability pressure is exactly what the full narrative for Kaspi.kz unpacks, revealing how Kaspi.kz could continue to accelerate its ecosystem while managing payout and risk trade offs.

Canadian Natural Resources (TSX:CNQ)

Overview: Canadian Natural Resources is a large Calgary based producer of crude oil, natural gas and NGLs that uses its upstream cash flows to support a well covered dividend above 3%.

Operations: Canadian Natural Resources generates about CA$21.3b from North America exploration and production, CA$20.8b from Oil Sands Mining and Upgrading, and CA$1.0b from Midstream and Refining.

Market Cap: CA$143.0b

For dividend investors, Canadian Natural Resources matters because its long life upstream barrels fund a 3%+ payout that management treats as a priority cash commitment.

"Heavy reliance on long life, zero or low decline Oil Sands mining and upgrading assets means future tightening of carbon pricing and methane rules could increase per barrel costs and compress net margins over time."

What happens to that dividend friendly cash engine will depend on how one unresolved policy pressure ultimately feeds through into future returns.

That policy risk is only half the story, and the full narrative for Canadian Natural Resources shows how Canadian Natural Resources could still accelerate shareholder returns as its asset mix and capital plans evolve.

Curious About What You Might Be Missing?

Fresh ideas can move fast. Some are building breakout momentum, others are still flying under the radar for now. Before the crowd catches on, get in early.

• Target resilient balance sheets and steady cash generators by scanning the curated list of solid balance sheet and fundamentals (198 results) while that quality premium still looks reasonable, and consider acting before sentiment shifts.
• Hunt for underfollowed opportunities by reviewing the hand picked 616 high quality undiscovered gems that may be dropping into investor focus only once early buyers are already in.
• Explore structural demand for critical materials by checking the focused 17 top copper producer stocks before capital flows react to the next supply squeeze and crowd the most sought after setups.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com